Bottom line
NVOH vs EFA: the short answer
NVOH (Novo Nordisk A/S (B Shares) ADRhedged) and EFA (iShares MSCI EAFE ETF) are both etfs.
But EFA is far broader, holding 691 positions to 3 for NVOH, so beyond the top names it adds exposure NVOH doesn't have.
NVOH is cheaper at 0.19% vs 0.32% — a difference of $13 a year per $10,000 invested.
Updated Nov 19, 2026
NVOH vs EFA side by side
| NVOH | EFA | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | DWS (Xtrackers) | iShares |
| Category | International Stock | International Stock |
| Expense ratio | 0.19% | 0.32% |
| Annual cost per $10k | $19 | $32 |
| 10-yr cost on $10k (prospectus) | $243 | $406 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | — | +3.4% |
| 5-yr return (annualized) | — | +4.7% |
| 10-yr return (annualized) | — | +5.1% |
| Best quarter | — | +18.1% |
| Worst quarter | — | −22.9% |
| Net assets (fund) | $4.2M | $78.0B |
| Number of holdings | 3 | 691 |
| Portfolio turnover | % | 4% |
| Returns as of | — | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
NVOH and EFA share none of their top holdings.
NVOH top 10
- Novo Nordisk A/s — 96.87%
- Dreyfus Trsry Securities — 2.79%
- Canadian Imperial Bank Of Commerce — -0.08%
EFA top 10
- ASML Holding N.V. — 2.90%
- Hsbc Holdings Plc — 1.66%
- Roche Holding AG — 1.39%
- Novartis AG — 1.30%
- Nestle S.A. — 1.17%
- Shell Plc — 1.17%
- Astrazeneca Plc — 1.17%
- Siemens Aktiengesellschaft — 1.10%
- Mitsubishi UFJ Financial Group, Inc. — 1.08%
- Bhp Group Limited — 0.97%
FAQ
What is the difference between NVOH and EFA?
NVOH (Novo Nordisk A/S (B Shares) ADRhedged) and EFA (iShares MSCI EAFE ETF) are both etfs. But EFA is far broader, holding 691 positions to 3 for NVOH, so beyond the top names it adds exposure NVOH doesn't have.
Which is cheaper, NVOH or EFA?
NVOH has the lower expense ratio (0.19%).
Should I own both NVOH and EFA?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.